Pregnancy outcomes in hiv-positive women in ukraine, 2000-12 (european collaborative study in eurocoord): An observational cohort study

The Lancet HIV

Volumn 2, Issue 9, 2015, Pages e385-e392

  Bagkeris, Emmanouil ^a   Malyuta, Ruslan ^b   Volokha, Alla ^c   Cortina Borja, Mario ^a   Bailey, Heather ^a   Townsend, Claire L ^a   Thorne, Claire ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Perinatal Prevention of AIDS Initiative   (Ukraine)

^c SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LOPINAVIR; RITONAVIR; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SOCIAL ISOLATION; UKRAINE; COMBINATION DRUG THERAPY; DRUG USE; EPIDEMIOLOGY; HIV INFECTIONS; INFANT; MOTHER; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VERTICAL TRANSMISSION;

ADULT; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; DRUG USERS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; UKRAINE;

EID: 84947020330     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00079-X     Document Type: Article

References (36)

1. UNAIDS. THE GAP REPORT. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014.
2. Ministry of Health of Ukraine. Ukraine harmonized AIDS response progress report. Reporting period: January, 2012-December, 2013. Kiev: Ministry of Health of Ukraine, 2013.
3. WHO. HIV/AIDS treatment and care in Ukraine. Copenhagen: World Health Organization, 2013.
4. Ministry of Health of Ukraine. Number of people receiving ART in Ukraine, 2013. 2013. http://ucdc.gov.ua/en/statistics/treatment/art (accessed May 12, 2015).
5. UNICEF, WHO, and World Bank. Levels & trends in child malnutrition, UNICEF-WHO-The World Bank, Joint Child Malnutrition Estimates. Washington, DC: World Health Organization, 2012.
6. WHO. World health statistics 2014. Geneva: World Health Organization, 2014.
7. Thorne C, Semenenko I, Pilipenko T, Malyuta R. Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study. BMC Infect Dis 2009; 9: 40.
8. Malyuta R, Newell ML, Ostergren M, Thorne C, Zhilka N. Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. Eur J Public Health 2006; 16: 123-27.
9. Bailey H, Townsend CL, Semenenko I, Malyuta R, Cortina-Borja M, Thorne C. Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine. Bull World Health Organ 2013; 91: 491-500.
10. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
11. Voltolini C, Torricelli M, Conti N, Vellucci FL, Severi FM, Petraglia F. Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions. Reprod Sci 2013; 20: 1274-92.
12. Ndirangu J, Newell ML, Bland RM, Thorne C. Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod 2012; 27: 1846-56.
13. Ellis J, Williams H, Graves W, Lindsay MK. Human immunodefi ciency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol 2002; 186: 903-06.
14. Boer K, Nellen JF, Patel D, et al. The AmRo study: pregnancy outcome in HIV-1-infected women under eff ective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 2007; 114: 148-55.
15. Townsend C, Schulte J, Thorne C, et al. Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG 2010; 117: 1399-410.
16. Watts DH, Williams PL, Kacanek D, et al. Combination antiretroviral use and preterm birth. J Infect Dis 2013; 207: 612-21.
17. Short CE, Taylor GP. Antiretroviral therapy and preterm birth in HIV-infected women. Expert review of anti-infective therapy. Expert Rev Anti Infect Ther 2014; 12: 293-306.
18. Lekhan V, Rudiy V, Richardson E. Ukraine: health system review. Health Syst Transit 2010; 12: 1-183, xiii-xiv.
19. Wabiri N, Taff a N. Socio-economic inequality and HIV in South Africa. BMC Public Health 2013; 13: 1037.
20. Jones MC, Pewsey A. Sinh-arcsinh distributions. Biometrika 2009; 96: 761-80.
21. Rigby RA, Stasinopoulos DM. Generalized additive models for location, scale and shape. J R Stat Soc Ser C Appl Stat 2005; 54: 507-44.
22. Barros AJ, Hirakata VN. Alternatives for logistic regression in crosssectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3: 21.
23. Greenacre MB, Blasius J, eds. Multiple correspondence analysis and related methods. Boca Raton, FL: Chapman and Hall, 2006.
24. Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88: 31-38.
25. Little RE, Gladen BC, Birmingham K, Shkyryak-Nyzhnyk ZA, Chyslovska N. Preterm birth rates in Avon County, England, and urban Ukraine. Eur J Obstet Gynecol Reprod Biol 2004; 113: 154-59.
26. Anda EE, Nieboer E, Wilsgaard T, Kovalenko AA, Odland JO. Perinatal mortality in relation to birthweight and gestational age: a registry-based comparison of northern Norway and Murmansk County, Russia. Paediatr Perinat Epidemiol 2011; 25: 218-27.
27. Danishevski K, Balabanova D, McKee M, Nolte E, Schwalbe N, Vasilieva N. Inequalities in birth outcomes in Russia: evidence from Tula oblast. Paediatr Perinat Epidemiol 2005; 19: 352-59.
28. Kissin DM, Mandel MG, Akatova N, et al. Five-year trends in epidemiology and prevention of mother-to-child HIV transmission, St. Petersburg, Russia: results from perinatal HIV surveillance. BMC Infect Dis 2011; 11: 292.
29. Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis 2012; 54: 1348-60.
30. Kreitchmann R, Li S, Melo V, et al. Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study. BJOG 2014; 121: 1501-08.
31. Thorne C, Semenenko I, Malyuta R. Prevention of mother-to-child transmission of human immunodefi ciency virus among pregnant women using injecting drugs in Ukraine, 2000-10. Addiction 2012; 107: 118-28.
32. Caixeta RB, Khoury RN, Sinha DN, et al. Current tobacco use and secondhand smoke exposure among women of reproductive age-countries, 2008-2010. MMWR Morb Mortal Wkly Rep 2012; 61: 877-82.
33. Aliyu MH, Weldeselasse H, August EM, Keith LG, Salihu HM. Cigarette smoking and fetal morbidity outcomes in a large cohort of HIV-infected mothers. Nicotine Tob Res 2013; 15: 177-84.
34. Vintzileos AM, Ananth CV, Smulian JC, Scorza WE, Knuppel RA. The impact of prenatal care in the United States on preterm births in the presence and absence of antenatal high-risk conditions. Am J Obstet Gynecol 2002; 187: 1254-57.
35. Fowler MG, Qin M, Shapiro D, et al. PROMISE: effi cacy and safety of 2 strategies to prevent perinatal hiv transmission. Conference on Retroviruses and Opportunistic Infections (CROI); Seattle, WA, USA. Feb 23-26, 2015. Abstr 31LB.
36. Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007; 21: 1019-26.